• About Adcendo
    • The Story
    • Leadership team
    • Board of Directors
    • Senior Scientific Founders
    • Clinical and Scientific Advisory Board
  • Our science
    • What are ADCs
    • The uPARAP receptor
    • Key publications
  • Investors
    • Corporate presentation
    • Press releases
    • Our investors
  • Careers
    • Open Positions
    • Company values
  • Contact

A urokinase receptor-associated protein with specific collagen binding properties (2000)

Apr 26, 2000

Recent Posts

  • Adcendo Appoints Dominik Mumberg, PhD, as Chief Scientific Officer
  • Data Presentation on uPARAP targeting ADCs in Osteosarcoma PDX Models at the 2022 AACR Annual Meeting
  • Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders
  • The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target (2021)
  • Adcendo Appoints Michael Pehl as Chief Executive Officer

Recent Comments

No comments to show.

Adcendo ApS

For all inquiries, please contact adcendo via the e-mail address info@adcendo.com



Privacy Policy
© Adcendo ApS, All rights reserved 2022